Formation, Clearance, Deposition, Pathogenicity, and Identification of Biopharmaceutical-related Immune Complexes
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Formation, Clearance, Deposition, Pathogenicity, and Identification of Biopharmaceutical-related Immune Complexes
Authors
Keywords
-
Journal
TOXICOLOGIC PATHOLOGY
Volume 42, Issue 4, Pages 725-764
Publisher
SAGE Publications
Online
2014-04-05
DOI
10.1177/0192623314526475
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Complement Activation Plays a Key Role in Antibody-Induced Infusion Toxicity in Monkeys and Rats
- (2014) T. Tawara et al. JOURNAL OF IMMUNOLOGY
- Immunogenicity of Subcutaneously Administered Therapeutic Proteins—a Mechanistic Perspective
- (2013) Anas M. Fathallah et al. AAPS Journal
- Immunoglobulin G1 and immunoglobulin G4 antibodies in multiple sclerosis patients treated with IFNβ interact with the endogenous cytokine and activate complement
- (2013) Swaminathan Sethu et al. CLINICAL IMMUNOLOGY
- Biomarkers for non-human primate Type-I hypersensitivity: Antigen-specific immunoglobulin E assays
- (2013) Darcey Clark et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Immunogenicity of mAbs in non-human primates during nonclinical safety assessment
- (2013) Peter J.K. van Meer et al. mAbs
- In Vivo Fluorescence Imaging of IgG1 Aggregates After Subcutaneous and Intravenous Injection in Mice
- (2013) Vasco Filipe et al. PHARMACEUTICAL RESEARCH
- Immunogenicity/Hypersensitivity of Biologics
- (2013) Michael W. Leach et al. TOXICOLOGIC PATHOLOGY
- Immunogenicity to Therapeutic Proteins: Impact on PK/PD and Efficacy
- (2012) Narendra Chirmule et al. AAPS Journal
- Impact of Antibodies to Infliximab on Clinical Outcomes and Serum Infliximab Levels in Patients With Inflammatory Bowel Disease (IBD): A Meta-Analysis
- (2012) Kavinderjit S Nanda et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Abatacept in subjects who switch from intravenous to subcutaneous therapy: results from the phase IIIb ATTUNE study
- (2012) Edward Clark Keystone et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical implications of variations in anti-infliximab antibody levels in patients with inflammatory bowel disease
- (2012) Casper Steenholdt et al. INFLAMMATORY BOWEL DISEASES
- Toxicologic Pathology in the 21st Century
- (2012) Robert A. Ettlin TOXICOLOGIC PATHOLOGY
- Regulatory Forum Opinion Piece*
- (2012) Michael W. Leach TOXICOLOGIC PATHOLOGY
- Immunogenicity, Safety, and Efficacy of Abatacept Administered Subcutaneously With or Without Background Methotrexate in Patients With Rheumatoid Arthritis: Results From a Phase III, International, Multicenter, Parallel-Arm, Open-Label Study
- (2012) Peter Nash et al. ARTHRITIS CARE & RESEARCH
- Clinical testing for neutralizing antibodies to interferon-β in multiple sclerosis
- (2012) Paul I. Creeke et al. Therapeutic Advances in Neurological Disorders
- Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: Prediction and prevention
- (2011) Janos Szebeni et al. ADVANCED DRUG DELIVERY REVIEWS
- Severe infusion reactions to infliximab: aetiology, immunogenicity and risk factors in patients with inflammatory bowel disease
- (2011) C. Steenholdt et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Aggregates in monoclonal antibody manufacturing processes
- (2011) María Vázquez-Rey et al. BIOTECHNOLOGY AND BIOENGINEERING
- The Role of the Toxicologic Pathologist in the Biopharmaceutical Industry
- (2011) Susan van Tongeren et al. INTERNATIONAL JOURNAL OF TOXICOLOGY
- Development of Antidrug Antibodies Against Adalimumab and Association With Disease Activity and Treatment Failure During Long-term Follow-up
- (2011) Geertje M. Bartelds JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Immunogenicity of Therapeutic Proteins: The Use of Animal Models
- (2011) Vera Brinks et al. PHARMACEUTICAL RESEARCH
- The effect of antibody isotype and antigenic epitope density on the complement-fixing activity of immune complexes: a systematic study using chimaeric anti-NIP antibodies with human Fc regions
- (2010) Y. M. LUCISANO VALIM et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Pharmacokinetics and Antibody Responses to the CD3 Antibody Otelixizumab Used in the Treatment of Type 1 Diabetes
- (2010) Geoff Hale et al. JOURNAL OF CLINICAL PHARMACOLOGY
- n-Dodecyl-β-d-Maltoside Inhibits Aggregation of Human Interferon-β-1b and Reduces Its Immunogenicity
- (2010) Robert A. Rifkin et al. Journal of Neuroimmune Pharmacology
- Evaluation of a generic immunoassay with drug tolerance to detect immune complexes in serum samples from cynomolgus monkeys after administration of human antibodies
- (2010) Kay Stubenrauch et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Safety and immunotoxicity assessment of immunomodulatory monoclonal antibodies
- (2010) Frank R. Brennan et al. mAbs
- The immunogenicity of humanized and fully human antibodies
- (2010) Fiona A. Harding et al. mAbs
- HIGH-MOLECULAR-WEIGHT AGGREGATES IN REPACKAGED BEVACIZUMAB
- (2010) Malik Y Kahook et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Neutrophil function in inflammation and inflammatory diseases
- (2010) H. L. Wright et al. RHEUMATOLOGY
- Incidences and Range of Spontaneous Findings in Control Cynomolgus Monkeys (Macaca fascicularis) Used in Toxicity Studies
- (2010) Ronnie Chamanza et al. TOXICOLOGIC PATHOLOGY
- Anti-infliximab IgE and non-IgE antibodies and induction of infusion-related severe anaphylactic reactions
- (2009) A. Vultaggio et al. ALLERGY
- Safety and tolerability of omalizumab
- (2009) J. Corren et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Serum sickness with an elevated level of human anti-chimeric antibody following treatment with rituximab in a child with chronic immune thrombocytopenic purpura
- (2009) Shoko Goto et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Ocular Inflammation in Cynomolgus Macaques Following Intravenous Administration of a Human Monoclonal Antibody
- (2009) P. L. Martin et al. INTERNATIONAL JOURNAL OF TOXICOLOGY
- Silicone Oil- and Agitation-Induced Aggregation of a Monoclonal Antibody in Aqueous Solution
- (2009) Renuka Thirumangalathu et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Immunogenicity of biologically-derived therapeutics: Assessment and interpretation of nonclinical safety studies
- (2009) Rafael Ponce et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
- The impact of infliximab infusion reactions on long-term outcomes in patients with Crohn’s disease
- (2008) A. C. MOSS et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The safety profile of anti-tumour necrosis factor therapy in inflammatory bowel disease in clinical practice: analysis of 620 patient-years follow-up
- (2008) C. W. LEES et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Allergic and Nonallergic Delayed Infusion Reactions During Natalizumab Therapy
- (2008) Kerstin Hellwig et al. ARCHIVES OF NEUROLOGY
- Stimulation of complement amplification by F(ab')2-containing immune complexes and naturally occurring anti-hinge antibodies, possible role in systemic inflammation
- (2008) Hans U. Lutz et al. AUTOIMMUNITY REVIEWS
- Systemic administration of an Fcγ–Fcε-fusion protein in house dust mite sensitive nonhuman primates
- (2008) Michael R. Van Scott et al. CLINICAL IMMUNOLOGY
- Efficacy and tolerability of intramuscular interferon beta-1a compared with subcutaneous interferon beta-1a in relapsing MS: results from PROOF
- (2008) Alireza Minagar et al. CURRENT MEDICAL RESEARCH AND OPINION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started